ArticleCureus2026
Advanced Presentation of GEMIN5 Neurodevelopmental Disorder in an Elderly Female.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
GEMIN5, an RNA-binding protein, recognizes small nuclear RNAs and delivers them to the survival motor neuron complex for assembly of small nuclear ribonucleoproteins, which is vital for the maintenance of motor neurons. Loss-of-function mutations in the GEMIN5 gene are associated with neurodevelopmental disorders. Biallelic GEMIN5 variants cause motor-predominant developmental delay and cerebellar atrophy. Clinically, GEMIN5 variants have been associated with neurodevelopmental disorder with cerebellar atrophy and motor dysfunction syndrome, which is characterized by developmental and cognitive delay, ataxia, motor dysfunction, hypotonia in infancy, and cerebellar atrophy. We report the case of a 79-year-old woman who presented with progressive ataxia, spastic paraparesis, contractures, bulbar dysfunction, and dementia on a background of learning difficulties. Two pathogenic variants in the GEMIN5 gene were identified by whole-genome sequencing following MRI findings of striking frontotemporal atrophy in addition to cerebellar atrophy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.